Panel Discussion | Closing the Disparity in Research

Saturday, March 7, 2026

8:40 AM - 9:10 AM EST

Location: Cabinet

Moderator(s)

Spencer B. King, III, MD, MACC, MSCAI

Professor of Medicine Emeritus
Emory University
Atlanta, Georgia, United States

Disclosure(s): No financial relationships to disclose
Karol Watson, MD, PhD

Attending Cardiologist
Ronald Reagan UCLA Medical Center
David Geffen School of Medicine at UCLA
Redondo Beach, California, United States

Disclosure information not submitted.

Panel Discussant(s)

Foluso A. Fakorede, MD

CEO
Cardiovascular Solutions Of Central Mississippi-Fusion Vascular
Grenada , Mississippi, United States

Disclosure(s): No financial relationships to disclose
Biljana Parapid, MD, PhD

Assistant Professor, Department of Medicine - Cardiology
Belgrade University School of Medicine
Belgrade, Serbia

Disclosure(s): No financial relationships to disclose
Dawn C. Scantlebury, MBBS, DM

Consultant Cardiologist
Queen Elizabeth Hospital, Barbados
Bridgetown, Saint Michael, Barbados

Disclosure(s): Aventa, Barbados: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 7, 2025); Merck: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, November 5, 2025)
Gregg W. Stone, MD, FACC, MSCAI

Physician
Mount Sinai
New York, New York, United States

Disclosure(s): Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter, Vascentis: Stock-privately held company (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Consulting Fees (e.g., advisory boards) (Terminated); Colibri, Remote Cardiac Enablement, Valfix, Zoll, HeartFlow, Shockwave, Ancora, Adona Medical, Abbott, HighLife, Elucid Bio, Aria, Alleviant, FBR Medical, Bioventrix, MedHub, Biotyx Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave, Biosense-Webster, Bioventrix, Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Pulnovo, V-wave and PCORI via Weill Cornell Medical Center.: Grant/Research Support (Ongoing)
Kim Allan Williams, Sr., MD, MACC, FAHA, MASNC, FESC

Chair, Department of Medicine
University of Louisville
Louisville, Kentucky, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Spencer B. King, MD, MACC, MSCAI, III: No financial relationships to disclose

Foluso A. Fakorede, MD: No financial relationships to disclose

Biljana Parapid, MD, PhD: No financial relationships to disclose

Dawn C. Scantlebury, MBBS, DM: Aventa, Barbados: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 7, 2025); Merck: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, November 5, 2025)

Gregg W. Stone, MD, FACC, MSCAI: Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter, Vascentis: Stock-privately held company (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Consulting Fees (e.g., advisory boards) (Terminated); Colibri, Remote Cardiac Enablement, Valfix, Zoll, HeartFlow, Shockwave, Ancora, Adona Medical, Abbott, HighLife, Elucid Bio, Aria, Alleviant, FBR Medical, Bioventrix, MedHub, Biotyx Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave, Biosense-Webster, Bioventrix, Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Pulnovo, V-wave and PCORI via Weill Cornell Medical Center.: Grant/Research Support (Ongoing)

Kim Allan Williams, MD, MACC, FAHA, MASNC, FESC, Sr.: No financial relationships to disclose